tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC

Arecor Therapeutics PLC (AREC) Financial Statements

1 Followers

Arecor Therapeutics PLC Financial Overview

Arecor Therapeutics PLC's market cap is currently ―. The company's EPS TTM is p-0.311; its P/E ratio is -4.64; Arecor Therapeutics PLC is scheduled to report earnings on September 19, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 12.81M£ 13.72M£ 18.32M£ 22.15M£ 2.90M
Total Assets£ 21.77M£ 17.31M£ 20.92M£ 23.55M£ 4.28M
Total Debt£ 288.00K£ 169.00K£ 231.00K£ 293.13K£ 2.00M
Net Debt£ -12.52M£ -13.55M£ -18.09M£ -21.86M£ -903.00K
Total Liabilities£ 4.31M£ 2.74M£ 2.37M£ 2.29M£ 3.51M
Stockholders Equity£ 17.45M£ 14.58M£ 18.55M£ 21.26M£ 774.00K
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Arecor Therapeutics PLC Earnings and Revenue History

Arecor Therapeutics PLC Debt to Assets

Arecor Therapeutics PLC Cash Flow

Arecor Therapeutics PLC Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis